More than 50 years of landmark results

Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.

Solutions for Complex Cases

Antitrust

Commodities

Data Privacy

Health Care

Securities

Professional Recommendations

“[Lowey Dannenberg] has considerable experience in litigating ‘some of the largest class actions throughout the country.’ . . . . The quality of their representation is also evidenced by the fact that Class Members, including sophisticated institutional investors, have not objected to the Settlement. The Court has no reason to doubt the quality of their representation.”

Hon. Gregory H. Woods, July 7, 2022 Fairness HearingTranscript, at p. 24 in In re JPMorgan Precious Metals Spoofing Litigation 18 Civ. 10356 (S.D.N.Y.)

“The court appreciates class counsel’s taking on these challenges and class counsel’s able navigation of these hard problems, in developing the case on behalf of the putative class, and in bringing contentious settlement negotiations to a successful outcome.

I might add too that the settlement was not only successful. Compared with many analogous cases, it was also prompt, a fact that brings obvious advantages to the class.”

Hon. Paul Engelmayer, May 31, 2022 Fairness Hearing Transcript, at p. 30 in In re JPMorgan Treasury Spoofing Litigation, 20 Civ. 3515 (S.D.N.Y.)

Recent Cases

Madoff feeder fund

Notable

By Vincent Briganti

Lowey Dannenberg served as lead counsel in litigation arising from Bernie Madoff’s Ponzi scheme. On March 15, 2013, the Honorable Colleen McMahon of the United States District Court for the […]

Read More

Xerox

Notable

By Vincent Briganti

Lowey Dannenberg served as class counsel, successfully challenging a multi-billion-dollar merger between Xerox Corp. and Affiliated Computer Systems (“ACS”), which overcompensated ACS’ former Chairman Darwin Deason at the expense of […]

Read More

Community Health Systems

Notable

By Vincent Briganti

Lowey served as lead counsel representing the New York City Pension Funds and the certified class of investors against one of the nation’s largest hospital systems, Community Health Systems (“CHS”).

Read More

News

Blog

Pharma Industry Takes Advantage of COVID Epidemic to Mislead Investors

May 16, 2021

Recently, several major players in the pharmaceutical industry have faced severe shareholder scrutiny for misleading the public regarding their roles in the production of COVID-19 vaccines. The company to most recently fall in the limelight is Emergent Biosolutions (“Emergent”). Emergent had...

Have a Case You Think We Can Help With?

Get Our Newsletter